Analyst picks & changes

By BC Staff | Jun 19, 1995 | 7:00 AM GMT

Genetics Institute Inc.

(GENIZ)

Oppenheimer's Geller said the suspension of Phase II trials of IL-12

Read the full 158 word article

How to gain access

Continue reading with a
two-week free trial.